AXNX Insider Trading Activity and SEC Form 4 Filings
AXNX insider trading summary
No open-market insider purchases or sales of Axonics, Inc. (AXNX) have been reported on SEC Form 4 in the past 12 months.
Latest AXNX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 2, 2024 | Kari Leigh Keese | Chief Financial Officer | Sell | $25K (364 @ $69.40) |
| Oct 2, 2024 | Kari Leigh Keese | Chief Financial Officer | Sell | $180K (2,597 @ $69.41) |
| Jan 31, 2024 | John Woock | EVP, Chief Mktg/Strtgy Officer | Sell | $1.1M (15,899 @ $67.74) |
| Jan 31, 2024 | Kari Leigh Keese | Chief Financial Officer | Sell | $236K (3,489 @ $67.74) |
| Jan 31, 2024 | Karen Noblett | Chief Medical Officer | Sell | $765K (11,288 @ $67.74) |
| Jan 31, 2024 | Raymond W Cohen | Chief Executive Officer | Sell | $2.4M (35,161 @ $67.74) |
| Jan 31, 2024 | Alfred J Ford Jr | Chief Commercial Officer | Sell | $1.1M (16,615 @ $67.74) |
| Jan 8, 2024 | Karen Noblett | Chief Medical Officer | Sell | $1.1M (15,999 @ $69.00) |
| Dec 28, 2023 | Karen Noblett | Chief Medical Officer | Sell | $446K (7,051 @ $63.28) |
| Dec 26, 2023 | Karen Noblett | Chief Medical Officer | Sell | $60K (949 @ $63.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.